Taliglucerase Alfa

Records for this ingredient, by country (identity only).

ATC A16AB11 · 5 markets · 6 records

Taliglucerase Alfa 5 markets · 6 records Forms
Filters
MarketAU 2US 1SG 1EU 1

AU 2 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 212 unit per mL / per unit basis not statedinjectionELELYSO taliglucerase alfa rpc 200 units powder for unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ELELYSO ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 200 unit/vial per mL / per unit basis not statedinjectionELELYSO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200 UNITS/ VIAL

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength · includes records with unknown status (not proof of sale)

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ELELYSO ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.